Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
BMC Microbiol ; 23(1): 352, 2023 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-37978423

RESUMO

BACKGROUND: Neisseria meningitidis can be carried asymptomatically in the human oropharynx without causing symptoms. Meningococcal carriage is relevant to the epidemiology of invasive meningococcal disease (IMD). No carriage studies have been performed among the general population in Lithuania, whereas the incidence of IMD in Lithuania was among the highest in European countries from 2009 to 2019. RESULTS: We analyzed a total of 401 oropharyngeal samples collected from university students from December 2021 to February 2023 for N. meningitidis carriage using direct swab PCR assays and culture. The overall carriage prevalence based on both or either swab PCR or culture was 4.99%. PCR-based assays were used to characterize 15 carriage isolates, including detection of genogroup, multilocus sequence typing profile, and typing of antigens PorA and FetA. The most common carriage isolates were capsule null locus (cnl), accounting for 46.7%, followed by genogroups B (26.7%) and Y (13.3%). We also performed a molecular characterization of invasive N. meningitidis isolates collected during the COVID-19 pandemic and post-pandemic period to understand better the meningococcal carriage in the context of prevailing invasive strains. Despite the substantial decrease in the incidence of IMD during the 2020-2022 period, clonal complex 32 (CC32) of serogroup B continued to be the most prevalent IMD-causing CC in Lithuania. However, CC32 was not detected among carriage isolates. The most common CCs were CC269, CC198, and CC1136. The antigen peptide variants found in most carried isolates were classified as 'insufficient data' according to the MenDeVAR Index to evaluate the potential coverage by the 4CMenB vaccine. Nearly half of the isolates were potentially covered by the Men-Fhbp vaccine. Resistance to ciprofloxacin was detected only for one cnl isolate. All isolates were susceptible to penicillin and ceftriaxone. Our analysis identified frequent partying (≥ 4 times/month) as a risk factor for meningococcal carriage, whereas smoking, living in a dormitory, and previous COVID-19 illness were not associated with the carriage. CONCLUSIONS: Our study revealed a low prevalence of meningococcal carriage among university students in Lithuania. The carriage isolates showed genetic diversity, although almost half of them were identified as having a null capsule locus.


Assuntos
Infecções Meningocócicas , Vacinas Meningocócicas , Neisseria meningitidis , Masculino , Humanos , Feminino , Neisseria meningitidis/genética , Infecções Meningocócicas/epidemiologia , Lituânia/epidemiologia , Pandemias , Universidades , Sorogrupo , Vacinas Bacterianas , Estudantes , Antígenos de Bactérias/genética
2.
J Gen Virol ; 91(Pt 3): 653-8, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19923267

RESUMO

Serological screening of sera from orang-utans demonstrated a high percentage of sera that cross-reacted with antigens of the polyomavirus (PyV) simian virus 40. Analysis of archival DNA samples from 71 Bornean and eight Sumatran orang-utans with a broad-spectrum PCR assay resulted in the detection of PyV infections in 11 animals from both species. Sequence analysis of the amplicons revealed considerable differences between the PyVs from Bornean and Sumatran orang-utans. The genome from two PyVs, one from each species, was therefore amplified and sequenced. Both viral genomes revealed a characteristic PyV architecture, but lacked an obvious agnogene. Neighbour-joining analysis positioned the viruses in a large cluster together with viruses from bats, bovines, rodents and several primate PyVs from chimpanzees, African green monkeys, squirrel monkeys and the human Merkel cell PyV.


Assuntos
Doenças dos Símios Antropoides/virologia , Infecções por Polyomavirus/veterinária , Polyomavirus/classificação , Polyomavirus/isolamento & purificação , Pongo abelii/virologia , Pongo pygmaeus/virologia , Infecções Tumorais por Vírus/veterinária , Sequência de Aminoácidos , Animais , Bornéu , Análise por Conglomerados , DNA Viral/química , DNA Viral/genética , Ordem dos Genes , Genes Virais , Indonésia , Dados de Sequência Molecular , Filogenia , Reação em Cadeia da Polimerase/métodos , Polyomavirus/genética , Infecções por Polyomavirus/virologia , Alinhamento de Sequência , Análise de Sequência de DNA , Sintenia , Infecções Tumorais por Vírus/virologia
3.
Vaccine ; 26(16): 1972-81, 2008 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-18343539

RESUMO

The preS1phil, a hydrophilic component of the hepatitis B virus (HBV) preS1 sequence, was exposed on the surface of three widely used virus-like particle (VLP) carriers by (i) insertion into the HI loop of the murine polyomavirus (MPyV) VP1, (ii) N-terminal addition to the hepatitis B surface (HBs) protein, and (iii) insertion into the major immunodominant region (MIR) of three hepatitis B core (HBc) vectors with different structure of their C-termini. Adjuvant-free immunisation of Balb/c mice demonstrated high preS1-specific antibody responses, but strong Th1 cell activation with efficient induction of IgG2a isotype antibodies was observed only in those VLPs, and namely in two of three HBc derivatives, which contained packaged RNA.


Assuntos
Anticorpos Antivirais/sangue , Antígenos de Superfície da Hepatite B/imunologia , Vacinas contra Hepatite B/imunologia , Hepatite B/imunologia , Imunização , Precursores de Proteínas/imunologia , Vírion/imunologia , Sequência de Aminoácidos , Animais , Anticorpos Antivirais/imunologia , Especificidade de Anticorpos , Proteínas do Capsídeo/genética , Proteínas do Capsídeo/metabolismo , Feminino , Antígenos do Núcleo do Vírus da Hepatite B/genética , Antígenos do Núcleo do Vírus da Hepatite B/metabolismo , Antígenos de Superfície da Hepatite B/química , Antígenos de Superfície da Hepatite B/genética , Vacinas contra Hepatite B/administração & dosagem , Vacinas contra Hepatite B/química , Vírus da Hepatite B/genética , Vírus da Hepatite B/metabolismo , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Injeções Subcutâneas , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos BALB C , Modelos Moleculares , Polyomavirus/química , Precursores de Proteínas/química , Precursores de Proteínas/genética , Células Th1/imunologia , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/imunologia , Proteínas do Envelope Viral/genética , Proteínas do Envelope Viral/metabolismo , Vírion/química , Vírion/metabolismo
4.
Virology ; 354(2): 252-60, 2006 Oct 25.
Artigo em Inglês | MEDLINE | ID: mdl-16904154

RESUMO

As polyomavirus major capsid protein VP1-derived virus-like particles (VLPs) have been demonstrated to be highly immunogenic, we studied their interaction with human dendritic cells (hDCs). Exposure of hDCs to VLPs originating from murine (MPyV) or hamster polyomavirus (HaPyV) induced hDC maturation. In contrast, exposure of hDCs to VLPs derived from human polyomaviruses (BK and JC) and simian virus 40 (SV40) only marginally induced DC maturation. The hDCs stimulated by HaPyV- or MPyV-derived VLPs readily produced interleukin-12 and stimulated CD8-positive T-cell responses in vitro. The highest frequencies of activated T cells were again observed after pulsing with HaPyV- and MPyV-derived VLPs. Monocyte-derived hDCs both bound and internalized the various tested polyomavirus VP1-derived VLPs with different levels of efficiency, partially explaining their individual maturation potentials. In conclusion, our data suggest a high variability in uptake of polyomavirus-derived VLPs and potency to induce hDC maturation.


Assuntos
Proteínas do Capsídeo/imunologia , Células Dendríticas/virologia , Polyomavirus/fisiologia , Vírion/fisiologia , Proteínas do Capsídeo/química , Proteínas do Capsídeo/genética , Células Dendríticas/imunologia , Células Dendríticas/metabolismo , Humanos , Polyomavirus/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA